Anna Meiliana
- Public Health, Environmental and Occupational Health top 2%
- Physiology top 2%
- Surgery top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Co-authors
- Andi WijayaMelisa Intan BarlianaKeri LestariMinato NakazawaHiroshi KoyamaSatomi KameoKenji KobayashiChiho Yamazaki
- Topics
- Adipose Tissue and Metabolism (19 papers)Adipokines, Inflammation, and Metabolic Diseases (15 papers)Cardiovascular Disease and Adiposity (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaFrontiers in PharmacologyDiabetes Research and Clinical Practice
- Partner nations
- IndonesiaSwitzerlandUnited States
In The Last Decade
Anna Meiliana
83 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Public Health, Environmental and Occupational Health 889
- Physiology 854
- Surgery 468
- Endocrinology, Diabetes and Metabolism 434
- Cardiology and Cardiovascular Medicine 402
Countries citing papers authored by Anna Meiliana
This map shows the geographic impact of Anna Meiliana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Meiliana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Meiliana more than expected).
Fields of papers citing papers by Anna Meiliana
This network shows the impact of papers produced by Anna Meiliana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Meiliana. The network helps show where Anna Meiliana may publish in the future.
Co-authorship network of co-authors of Anna Meiliana
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Meiliana. A scholar is included among the top collaborators of Anna Meiliana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Meiliana. Anna Meiliana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 5 | |
| 10 | 5 | |
| 11 | 18 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 9 | |
| 15 | 1 | |
| 16 | 4 | |
| 17 | 26 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.breakdown → | 2507 |
About Anna Meiliana
Anna Meiliana is a scholar working on Aging, Geriatrics and Gerontology and Physiology, having authored 89 papers that have together received 2.9k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (19 papers), Adipokines, Inflammation, and Metabolic Diseases (15 papers) and Cardiovascular Disease and Adiposity (7 papers). The work is most often cited by research in Pharmacy (365 citations), Physiology (854 citations) and Public Health, Environmental and Occupational Health (889 citations). Anna Meiliana has collaborated with scholars based in Indonesia, Switzerland and United States. Frequent co-authors include Andi Wijaya, Melisa Intan Barliana, Keri Lestari, Minato Nakazawa, Hiroshi Koyama, Satomi Kameo, Kenji Kobayashi, Chiho Yamazaki, Rizky Abdulah and Ronny Lesmana. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Pharmacology and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.